Marcy Powell

Publication Activity (10 Years)

Years Active: 2021-2022
Publications (10 Years): 4

Top Topics

Signaling Pathway

Top Venues

Pharmaceutical research

JMIR formative research

European journal of drug metabolism and pharmacokinetics

Medical Doctor Associates

University of North Carolina at Chapel Hill (BSC)

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Medical Doctor Associates Dec 20 2013

United States

Locum Tenen Coverage at NC hospitals :: OB/Gyn

GlaxoSmithKline Aug 29 2011

United States

Senior Medical Director :: Safety and Medical Governance

Durham Women's Clinic Aug 01 2006

United States

Physician partner :: OB/Gyn

Duke University Health System Aug 01 2006 - Aug 31 2011

United States

Attending Physician for residents and medical students :: OB/Gyn

Education History

University of North Carolina at Chapel Hill Aug 15 1990 - May 10 1995

United States

BSC :: Pharmacy

Publications

Debra J Tompson, Mark Whitaker, Rennan Pan, Geoffrey S Johnson, Teresa Fuller, Vanessa Zann, Litza McKenzie, Kathy Abbott Banner, Simon J Hawkins, Marcy Powell
Development of a Once-Daily Modified-Release Formulation for the Short Half-Life RIPK1 Inhibitor GSK2982772 using DiffCORE Technology. Pharmaceutical research 39 (1) (2022)
Jeanne M Pimenta, Jeffery L Painter, Kim Gemzoe, Roger Abramino Levy, Marcy Powell, Paige Meizlik, Gregory Powell
Identifying Barriers to Enrollment in Patient Pregnancy Registries: Building Evidence Through Crowdsourcing. JMIR formative research 6 (5) (2022)
Debra J Tompson, Carwyn Davies, Nicola E Scott, Edward P Cannons, Michalis S Kostapanos, Annette S Gross, Marcy Powell, Hiroko Ino, Ryutaro Shimamura, Hirofumi Ogura, Takashi Nagakubo, Harue Igarashi, Atsushi Nakano
Comparison of the Pharmacokinetics of RIPK1 Inhibitor GSK2982772 in Healthy Western and Japanese Subjects. European journal of drug metabolism and pharmacokinetics 46 (1) (2021)
Debra J Tompson, Mark Whitaker, Rennan Pan, Geoffrey S Johnson, Teresa Fuller, Litza McKenzie, Vanessa Zann, Marcy Powell, Kathy Abbott Banner, Simon J Hawkins
Development of a Prototype, Once-Daily, Modified-Release Formulation for the Short Half-Life RIPK1 Inhibitor GSK2982772. Pharmaceutical research 38 (7) (2021)